First Posted: May 07, 2021 04:44 AM EDT
Photo : Photo by Frazer Harrison/Getty Images
To help schools eyeing a return to in-person classes, San Diego biotech Biocept is bringing coronavirus testing to community colleges throughout the state of California.
The company recently announced a testing partnership with the Foundation for California Community Colleges, a nonprofit group that supports 116 community colleges in the area, serving more than 2 million students. The included schools will be able to administer coronavirus tests to students and staff, send samples to the local lab of Biocept and receive results within 48 hours.
According to The San Diego Union-Tribune, Biocept CEO Michael Nall stated that biotech started to offer coronavirus testing around last year after the company realized that it had the equipment, expertise, and laboratory certifications to run the tests. He also added that Biocept started to use a test made by Thermo Fisher to detect genetic material from
Print
San Diego biotech Biocept is bringing coronavirus testing to community colleges throughout California in a bid to help schools eyeing a return to in-person classes.
The company recently announced a testing partnership with the Foundation for California Community Colleges, a nonprofit supporting 116 community colleges that serves 2.1 million students. These schools will be able to administer COVID-19 tests to students and staff, send samples to Biocept’s local lab and receive results within 48 hours.
It’s an unusual pivot for Biocept, a company that mainly focuses on developing new ways to detect cancer sooner. But then again, the past year has been nothing if not unusual.
Biocept offers coronavirus tests for California community colleges, hosts neuro-oncology webinar
Biocept Inc (NASDAQ:BIOC) CEO Mike Nall tells Proactive it is partnering with the Foundation for California Community Colleges to make coronavirus testing available for the state‘s 116 community colleges and its more than 2.1 million students.
Through the Foundation’s CollegeBuys program, Naill said its PCR-based COVID-19 test is now available for community colleges to purchase for students, faculty, and staff.
Separately, the group recently hosted a Neuro-Oncology KOL Webinar, which can be accessed on Biocept s website.
Quick facts: Biocept Inc
Biocept makes coronavirus testing available for California’s 116 community colleges
Through a partnership with the Foundation for California Community Colleges, the company s PCR-based coronavirus (COVID-19) test is now available for the schools to purchase for students, faculty, and staff More than 2.1 million students are enrolled in California s community college system
Biocept Inc (NASDAQ:BIOC) has said it is partnering with the Foundation for California Community Colleges to make coronavirus (COVID-19) testing available for the state‘s 116 community colleges and their more than 2.1 million students.
Through the Foundation’s CollegeBuys program, Biocept said its PCR-based COVID-19 test is now available for community colleges to purchase for students, faculty, and staff.
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA: A2PN34) has said its Swiss hosted Sekur encrypted email, encrypted messaging and secure file-share solution will be featured on the Reason Foundation s Reason.com website through a series of paid informercials in a Podcast called The Reason Roundtable . The Podcasts are scheduled to start on May 10 2021 and are scheduled on a weekly basis with informercial spots of 30 and 60 seconds each week. There will be a total of 31 informercials planned until December 31 2021. The company has received the guarantee of minimum 23,000 downloads per podcast episodes. This puts Sekur in front of tens of thousands of listeners in a targeted audience seeking privacy and security in their data and communications. Additionally, the Company plans several sponsored email ads with Reason.com. Alain Ghiai